Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | 12-2002 | |
| Gross Profit | N/A | N/A | N/A | N/A | 22,410 |
| Operating Expenses | 24,116 | 0 | 0 | 0 | 5,940 |
| Operating Income | -24,116 | N/A | N/A | N/A | -5,940 |
| Other Income | 653 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -23,463 | 0 | 0 | 0 | -5,940 |
| Net Income Continuous | -23,463 | N/A | N/A | N/A | -5,940 |
| Net Income | $-23,463 | $N/A | $N/A | $N/A | $-5,940 |
| EPS Basic Total Ops | -133.60 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -133.61 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -133.60 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -133.61 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-24,102 | $N/A | $N/A | $N/A | $-2,200 |